Lucy Lu

2021 - AVENUE THERAPEUTICS

In 2021, Lucy Lu earned a total compensation of $1.1M as Chief Executive Officer at AVENUE THERAPEUTICS, a 144% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$233,079
Salary$454,647
Stock Awards$382,803
Other$11,600
Total$1,082,129

Lu received $454.6K in salary, accounting for 42% of the total pay in 2021.

Lu also received $233.1K in non-equity incentive plan, $382.8K in stock awards and $11.6K in other compensation.

Rankings

In 2021, Lucy Lu's compensation ranked 8,522nd out of 12,415 executives tracked by ExecPay. In other words, Lu earned more than 31.4% of executives.

ClassificationRankingPercentile
All
8,522
out of 12,415
31st
Division
Manufacturing
3,778
out of 5,505
31st
Major group
Chemicals And Allied Products
1,673
out of 2,375
30th
Industry group
Drugs
1,490
out of 2,096
29th
Industry
Pharmaceutical Preparations
1,110
out of 1,546
28th
Source: SEC filing on November 18, 2022.

Lu's colleagues

We found one more compensation record of an executive who worked with Lucy Lu at AVENUE THERAPEUTICS in 2021.

2021

Joseph Vazzano

AVENUE THERAPEUTICS

Chief Financial Officer

News

You may also like